baber/WOPTO huggingface dataset:
Patent DK-118882-A (DK)
Inventor: WISSLER J H
IPC: A61K39/395
Filed: 1982-03-17
Abstract: The invention relates to new mitogens of leukocytes and inflamed tissue which have the biological and physicochemical properties stated in the claims. The compounds selectively induce the division and differentiation of leukocytes and their precursors in the bone marrow. The invention also relates to a biotechnical process for preparing and isolating the mitogens and to pharmaceutical compositions containing them.
Patent DK-128387-A (DK)
Inventor: INGVORSEN KJELD
IPC: C12N15/52
Filed: 1987-03-12
Abstract: A novel cyanide converting enzyme, a "cyanidase" is described. The enzyme is extremely efficient in reducing substantial amounts of cyanide to very low levels in a broad pH, and temperature range, and in the presence of organics and metal ions.
Patent DK-188682-A (DK)
Inventor: BEYTS P K
IPC: A23L27/30
Filed: 1982-04-27
Abstract: Synergised compositions contain a mixture of different sweetening agents, at least one of which is saccharin, stevioside, acesulpham K or other sweetening agent with an associated bitter taste, and at least another of which is a chlorodeoxysucrose, chlorodeoxygalactosucrose or other sweetening agent which is a chlorodeoxysugar.
Patent DK-223085-A (DK)
Inventor: GRECO ALBERTO
IPC: C07F7/08
Filed: 1985-05-20
Abstract: Reactive stabilising compounds, able to stabilise organic polymers, contain in their molecule a sterically hindered amino group and a hydrolysable silyl function. 
<??>In stabilising organic polymers, said reactive stabilising compounds can be hydrolysed at the silyl function with the formation of silanol groups, which are made to interact in order to form complex resinous stabilising structures. These latter are added in stabilising quantities to the polymer to be stabilised. 
<??>According to one particular embodiment, the hydrolysis at the silyl function and the formation of the resinous structure take place spontaneously within the polymer to be stabilised. 
<??>According to a further embodiment, the reactive stabilising compound is added to the polymer after being stably supported on a solid support by reaction with an inorganic solid having surface hydroxyl groups. 
<??>According to a further embodiment, the reactive stabilising compound is made to interact with the polymer so that the stabilising compound becomes chemically bonded to the polymer chains. 
<??>In all cases, stabilised polymers are obtained containing the stabilising compound in a form which is not removable from the polymer. 
<??>The process for preparing the reactive stabilising compounds and for preparing the stabilised polymer compositions are also described.
Patent DK-225579-A (DK)
Inventor: HORSTMANN H
IPC: C07D417/04
Filed: 1979-05-30
Abstract: The present invention relates to certain new imidazo [2,1-b]-[1,3,4]-thiadiazole compounds, to the provision of pharmaceutical compositions containing said compounds and to the use of said compounds and compositions as antithrombotic agents and thrombolytic agents.
Patent DK-251683-A (DK)
Inventor: PERSSON AAKE RAGNAR
IPC: B62D27/06
Filed: 1983-06-02
Abstract: A quick socket and a strut, especially for transport vehicles, and comprising a strut and a socket fitting thereto and comprising a carrier portion (3) and a locking portion (4), in which the carrier portion (3) is adapted to receive the strut with some play, and in which the locking portion (4) is formed with one or more key means (9, 10), which are resiliently biassed in the direction upwards-inwards towards the center of the carrier portion (3) whereby the key means press the strut to a play-free contact with the carrier portion (3). The key means (9, 10) is/are slidable in obliquely extending slots (11) in the sides of the locking portion. For positively securing the strut against un-intentional removal from the quick socket, the quick socket has a bayonet like locking groove (6, 7), which cooperates with a projecting shoulder of the strut.
Patent DK-347682-A (DK)
Inventor: RUTTER W J
IPC: C12N1/16
Filed: 1982-08-03
Abstract: The present invention relates to synthesis of HBsAg in yeast. Yeast expression vectors comprising a yeast promoter, ADHI, have been constructed. The region of the HBV genome coding for the S-protein, excluding a possible 163 amino acid presequence, has been transferred to the yeast expression vector. Using the described yeast vector, the successful synthesis of HBsAg by yeast has been achieved. The product is antigenic (reactive with anti-HBsAg), and a substantial portion is found associated with particles identical in electron microscopic appearance to those found in the serum of HBV-infected patients and in Alexander cells but having a smaller particle size diameter. The HBsAg synthesized by yeast has identical sedimentation behavior to purified, naturally-occurring HBsAg particles purified from Alexander cells as measured by sucrose gradient sedimentation. The present invention demonstrates synthesis and assembly of a higher ordered multi-component structure resulting from expression of a heterologous DNA coding segment in a microorganism.
Patent DK-351187-A (DK)
Inventor: PEREZ BERNARDO ALCANTARA
IPC: G06K15/16
Filed: 1987-07-07
Abstract: The subject of this invention is the design of a mechanism for the feed of the paper in a flat plotter for drawing, which is cheap and has a high level of operational reliability. The mechanism consists of a reduction motor which rolls up the paper after it has passed through the drawing zone; in the drawing head an optical line reader is fitted which is designed to read a trace made by the drawing tool once the drawing has been completed in one window; when this trace is detected, a stop command is delivered to the rolling-reducer motor. Once the paper feed has stopped, in order to exactly join and continue the drawing of the following window in the correct form, the drawing tool carries out a search for the trace at very low speed. When the line has been detected in this process, the plotter continues with the drawing operation in the correct place.
Patent DK-408187-A (DK)
Inventor: KAMIN HARTMUT
IPC: A47B88/80
Filed: 1987-08-05
Abstract: In a money till with a box-shaped housing (10), whose upper side is partially closed by a stationary cover (12) and partially closed by a lid (16), the lid includes two lid parts (18, 20) connected with one another about a pivot axis (22), the first lid part (18) which is closer to the stationary cover (12) being guided for sliding movement parallel to the stationary cover (12), whereas the second lid part (20) is connected with at least one guide element (34) which, at a radial spacing from the pivot axis (22), is engaged with a cam curve (36) so that upon a sliding of the lid (16) the second lid part (20) is pivoted between a closed position and an open position.
Patent DK-429380-A (DK)
Inventor: SEP W J
IPC: C08L67/06
Filed: 1980-10-10
Abstract: The invention provides novel curable unsaturated polyester compositions comprising an unsaturated polyester, a reactive copolymerizable monomer, a paraffin wax as an evaporation-reducing agent and as an adhesion promotor a compound, containing 10-30 carbon atoms, of the class consisting of alkylaromatic, alkenylaromatic, alkylolaromatic compounds or an alcohol.
Patent DK-434187-A (DK)
Inventor: ADLER-MOORE JILL
IPC: A61K9/127
Filed: 1987-08-20
Abstract: Formulations consisting of phospholipid small unilamellar particles encapsulating polyene antifungal antibiotics and methods for using such compositions to treat systemic fungal infections are described. In a preferred embodiment, the particles are in the form of vesicles which comprise a polyene antifungal antibiotic, preferably amphotericin B and/or nystatin, egg phosphatidylcholine and cholesterol, preferably in the molar ratio of about .2 (AMB):2(PL): 1(CHOL). These vesicles may also have an amine modified surface. The vesicles are suspended in a low ionic strength saccharide/tris solution at a pH of from about 6.0 to about 8.0 and may be administered to deliver the antifungal antibiotic to treat systemic fungal infections.
Patent DK-437379-A (DK)
Inventor: ABEELS P F
IPC: B60C3/00
Filed: 1979-10-17
Abstract: 1. Tyre having a flexible envelope comprising an inner chamber and provided with lugs, intended for agricultural or foresty tractors, particularly for the driving wheels of the said tractors, which may be fitted on a conventionnal rim (2) and comprising a tread, a pair of sidewalls (5, 6) connected along the edges of the tread and a pair of beads (3) located on the other end of the sidewalls (5, 6) to fit the tyre on the rim (2), the tread having an extension (b) relatively to the outer edge on which the beads (3) of the tyre rest on the rim (2) of at least a quarter of half of the width (a) of the tread, characterized by the fact that the maximum width (c) of the inner chamber (4) of the tyre, defined by the tread and the sidewalls (5, 6) is less that the space (d) between the outer edges on which the beads (3) of the tyre rest on the rim (2) in order to sustain the sidewalls (5, 6).
Patent DK-498081-A (DK)
Inventor: NILSSON S M
IPC: F28D19/04
Filed: 1981-11-11
Abstract: The invention concerns a roll (12) comprising two superposed webs (6, 7) of material one (6) of which is formed with transverse ridges (10). At the ridge bases and tops are formed indentations (22). The other web (7) is provided with ribs (27) which are positioned in nesting relationship in the indentations, whereby the webs are secured to one another. The invention likewise concerns a method and a machine for manufacturing rolls of this kind.
Patent DK-580984-A (DK)
Inventor: JONASSON VOLLMAR
IPC: B29C63/26
Filed: 1984-12-05
Abstract: A method and an apparatus are described for lining an existing pipeline 1 such as a water or drainage pipe in the ground by means of a flexible hose 4, which contains a thermosetting plastic material, and which is introduced into the pipeline with the plastic material in the non- set condition and is then rendered dimensionally stable by setting of the plastic material. A fast and effective hardening is achieved of the plastic material in the hose 4, once this has been pressed out against the walls of the pipeline 1 by means of compressed air, the hose being exposed to radiant energy from a radiation source 19 on a thermosetting unit 18 that is drawn through the hose 4, at the same time that a flow of air is passed through the hose. <IMAGE>
Patent DK-586783-A (DK)
Inventor: MELIN PER OLOF RAGNAR
IPC: A61K38/095
Filed: 1983-12-20
Abstract: Novel vasotocin derivatives having an inhibitory effect on uterine contractions, pharmaceutical compositions containing these derivatives, and the use thereof in the therapeutical treat- nent of excessive muscle contractions in the uterus are described. The derivatives differ from vasotocin in that the structure of the original hormone has been modified at positions 1, 2 and, optionally, 4 and/or 8. The vasotocin derivatives thus iave the formulawhereinMpa is a 3-mercaptopropionyl residue (-S-CH<sub>2</sub>- CH<sub>2</sub>-CO-);A is the peptide residue of L- or D-tyrosine-O-ethyl ether (in other words, 4-ethoxy-L or D-phenyl alanine, i.e. L-or D-Tyr(Et)), or of a hydrophopic D-amino acid, such as D-tyrosine(D-Tyr) or D-tryptophane(D-Trp);Ile is the peptide residue of isoleucine;B is the peptide residue of glutamine (Gin), treonine (Thr) or valine (Val);Asn is the peptide residue of asparagin;Cys is the peptide residue of cysteine;Pro is the peptide residue of proline;C is the peptide residue of L- or D-arginine (Arg), ornithine (Orn) or citrullin (Cit); andGly-NH<sub>2</sub> is the peptide residue of glycine amide.
Patent FI-834634-A (FI)
Inventor: MELIN PER OLOF RAGNAR
IPC: A61K38/095
Filed: 1983-12-16
Abstract: Novel vasotocin derivatives having an inhibitory effect on uterine contractions, pharmaceutical compositions containing these derivatives, and the use thereof in the therapeutical treat- nent of excessive muscle contractions in the uterus are described. The derivatives differ from vasotocin in that the structure of the original hormone has been modified at positions 1, 2 and, optionally, 4 and/or 8. The vasotocin derivatives thus iave the formulawhereinMpa is a 3-mercaptopropionyl residue (-S-CH<sub>2</sub>- CH<sub>2</sub>-CO-);A is the peptide residue of L- or D-tyrosine-O-ethyl ether (in other words, 4-ethoxy-L or D-phenyl alanine, i.e. L-or D-Tyr(Et)), or of a hydrophopic D-amino acid, such as D-tyrosine(D-Tyr) or D-tryptophane(D-Trp);Ile is the peptide residue of isoleucine;B is the peptide residue of glutamine (Gin), treonine (Thr) or valine (Val);Asn is the peptide residue of asparagin;Cys is the peptide residue of cysteine;Pro is the peptide residue of proline;C is the peptide residue of L- or D-arginine (Arg), ornithine (Orn) or citrullin (Cit); andGly-NH<sub>2</sub> is the peptide residue of glycine amide.
Patent FI-840929-A (FI)
Inventor: MAIER GERHARD
IPC: H03J7/06
Filed: 1984-03-07
Abstract: A method and apparatus is provided for the tuning of the resonant circuits of a communications receiver. The frequency fD is generated with an additional oscillator, which frequency is then mixed with the receiver oscillator frequency, of which three frequencies fo, fo+fD, fo-fD are formed and are applied to the antenna output. The frequency fD, which is evaluated as a narrow band, is generated by mixing at the intermediate frequency output. A maximum balancing is provided over all high-frequency circuits. The acceptor circuits are tuned to fo and fo+fD (N+5, N+11) for obtaining maximum damping of the oscillator frequency and of the mirror frequency, where N+5 and N+11 represent mirror frequencies.
Patent FI-840934-A (FI)
Inventor: WESTERGAORD RUNE
IPC: B60C23/20
Filed: 1984-03-08
Abstract: The invention relates to a method and a device for monitoring the temperature of a moving member (e.g. a bearing) (3), by means of a signal generated when the temperature of the member exceeds a certain limiting control temperature. The signal is conducted to a central supervisory unit supervising the operation of the moving member. In thermal contact with the moving member (3) is located a thermal release device (10-13) which trips when the temperature exceeds the control temperature. Close to the path of motion of the member a sensing means (4) is disposed, this means (4) sensing when the thermal release device (10-13) has tripped and transmits a signal indicating this to the central supervisory unit. The thermal release device may be a bimetal strip or comprise a memory metal, or alternatively it may incorporate solder which melts to release as indicator which is then moved by a spring or small explosive charge. <IMAGE>
Patent FI-871047-A (FI)
Inventor: HORVEI KNUT
IPC: F16K5/20
Filed: 1987-03-10
Abstract: A ball valve device for subsea applications, particularly intended to be connected into subsea pipeline systems which lead a flowing medium (gas and/or oil) in subsea condition, capable of being dismantled for inspection and maintenance. The ball arrangement of the valve consists of an upper ball member (3), and a lower ball member (4) the upper ball member (3) includes the main packings of the valve, while the lower ball member (4) includes two axially withdrawable sleeves (13). When the valve is open the sleeves (13) can be withdrawn outwards for intervention with guides in the valve housing (1) and thereby form a tight continuous passageway which extends from one of the openings in the valve housing (1) to the second opening in the valve housing (1). The axial withdrawable sleeves (13) can be moved inwards to a position where they are free from its other guides to allow the ball arrangement to rotate during closing of the valve.
Patent FI-883643-A (FI)
Inventor: SANDOW JUERGEN KURT
IPC: A61K47/42
Filed: 1988-08-04
Abstract: The invention relates to the use of aids of the general formula <IMAGE>  in which B denotes a basic amino acid, A/B denotes an acidic or basic amino acid, X denotes a neutral and hydrophilic amino acid, L denotes a lipophilic neutral amino acid, and R denotes hydrogen or an acyl radical, or the physiologically tolerated salts thereof, for promoting the absorption of peptides and proteins on administration onto the mocosa, as well as to pharmaceutical compositions which contain a pharmacologically effective amount of one or more peptides or proteins as well as an aid of the abovementioned formula.
Patent FI-885611-A (FI)
Inventor: REUTER ALFRED
IPC: B27B5/22
Filed: 1988-12-02
Abstract: A cross-cutting saw for cutting boards 3 at their two ends has a cross-conveyor device 1 on which the boards are transported. In two separate saw slides 8,9, two sets of cross-cutting saw units 17 are placed such that the units can individually be swung in over the motional path of the cross-conveyor device 1 in order to carry out cross-cut sawing of the boards. Both saw slides 8,9 are placed on a common pilot carrier 7 so that they can individually be moved and adjusted in the longitudinal direction. <IMAGE>
Patent FI-892243-A (FI)
Inventor: HENRICSON KAJ
IPC: D21C9/10
Filed: 1989-05-10
Abstract: The present invention relates to a method of bleaching cellulose pulp with ozone. Ozone bleaching has been extensively studied in laboratory and pilot scale. It has been proved that at low consistencies, i.e. less than 5 %, ozone dissolves well in water and thus good transfer of substance between the ozone and the fibers in the water is achieved. On the other hand, it has been discovered that the ozone, being a gaseous substance, reacts well also directly with a fiber surface which, however, presupposes that the consistency of the suspension is over 25 %. Further, it has been discovered that in the intermediate range between said consistencies ozone cannot satisfactorily contact the fibers. However, both environmental and pumping factors determine the operation to be carried out at that particular intermediate consistency range of 5 to 25 %. A characteristic feature of the method of the present invention, which avoids the disadvantages of prior art methods and permits operation at the consistency range of 5 to 25 %, is that cellulose pulp is pumped with a high-consistency pump to a fluidizing mixer in which O2/O3 gas is introduced and mixed into the pulp so as to generate foam in which the fibers in the pulp and the ozone used as the bleaching agent are brought to contact with each other, and that the pulp is discharged from the mixer to a reaction vessel.
Patent FI-900135-A (FI)
Inventor: KNIPP HERBERT
IPC: B29C67/20
Filed: 1990-01-10
Abstract: Latex foam has been produced to date in metal moulds which are preferably heated with steam. In the case of deep moulds, the gelling and vulcanisation time is long; the process requires expensive apparatus and is not very economical in terms of energy. The latex foam is introduced into a mould of nonmetallic material, the temperature of which at the surface in contact with the latex foam can be between 45 DEG C and 100 DEG C, and the said foam is brought to a temperature of up to 100 DEG C in the course of 3 to 10 minutes by means of microwaves, the foam being vulcanised. Thick foam elements also have a very uniform pore structure and a uniform elongation at break. Production of latex foam in constant quality even in a thick layer under economical conditions.
Patent FI-912124-A (FI)
Inventor: WUSTROW DAVID J
IPC: A61P13/02
Filed: 1991-05-02
Abstract: Novel pyrido[2,3-f][1,4]thiazepines and novel pyrido[3,2-b][1,5]benzothiazepines are described. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity. Also described are methods of producing the novel compounds and intermediates thereof.
Patent FI-913040-A (FI)
Inventor: LAESPAE MATTI
IPC: F24D/
Filed: 1991-06-20
Abstract: Central heating unit consisting of a solid fuel furnace 1 in which fuel is burned, ducts leading from the furnace to the chimney, a heat-insulated reserve space 9 in conjunction with which the furnace 1 is arranged so that water surrounds it at least partially and a discharge tube 15 and return tube 27 connected to the reserve space for connection of the central heating unit to a central heating network.  The invention has been implemented so that a pump and network space 11 is arranged in the heat insulation 26 of the central heating unit, which contains at least one circulating water pump 12 and the necessary devices for connection of the central heating unit to the central heating network and an operating water line, and that the discharge tube 15 is arranged in the reserve space 9 so that the upper end 16 of tube 15 is positioned at a predetermined height and the other end of tube 15 is connected to the circulating water pump 12 in the pump and network space 11. <IMAGE>
Patent FI-913693-A (FI)
Inventor: D HERBECOURT BRUNO
IPC: C09D5/29
Filed: 1991-08-02
Abstract: Multicolour coating, especially for metal substrates. It consists of a surface coat comprising a dispersion in a colourless varnish of bulk-coloured thermoplastic resin powders and optionally of an undercoat of a tint which is uniform to the eye, with at least one of the tints of the powders of a colour other than that of the undercoat.
Patent FI-914621-A (FI)
Inventor: FAULL ALAN WELLINGTON
IPC: C07D263/26
Filed: 1991-10-02
Abstract: The invention concerns novel 1,3-dioxane alkenoic acid derivatives of the formula I <CHEM>  wherein: n is the integer 1 or 2;  Y is methyleneoxy, vinylene or ethylene;  A<1> is (1-6C)alkylene;  R<1> is a group of the formula R<2>.A<2>-, in which: R<2> is phenyl unsubstituted or bearing up to three substituents which are independently selected from (1-6C)alkyl, (1-6C)alkoxy, (2-6C)alkanoyl (1-6C)alkylthio, (1-6C)alkylsulphonyl, halogeno, trifluoromethyl, nitro and cyano; A<2> is a direct bond to R<2> or a group of the formula -W-C(R<4>)(R<5>)-wherein W is oxygen, methylene or a direct bond to R<2>, and R<4> and R<5> are independently (1-4C)alkyl; Q is a heterocyclyl group selected from thiazol-5-yl and imidazol-5-yl, the latter being unsubstituted or bearing a (1-12C)alkyl group at the 1-position of the imidazole ring; and R<3> is hydroxy, a physiologically acceptable alcohol residue, or (1-4C)alkanesulphonamido; or a pharmaceutically acceptable salt thereof. The compounds are thromboxane A2 antagonists and inhibitors of thromboxane A2 synthase, and are useful on the treatment of a variety of diseases in which thromboxane A2 is involved, such as is ischaemic heart disease, cerebrovascular disease and peripheral vascular disease. The invention also includes processes for the manufacture and use of the compounds, and pharmaceutical compositions containing them.
Patent FI-914993-A (FI)
Inventor: BEERENDS JOHN GERARD
IPC: H03M7/30
Filed: 1991-10-23
Abstract: Frequency components are calculated from the STP-filtered speech signal. The amplitudes of these are combined in a manner such that the resultant values are associated with frequencies which are situated equidistantly on a linear Bark scale. Said components are quantised, possibly after scaling. In the decoder, the components are again distributed over the frequency spectrum. In the coder, the fundamental regularity D is determined with an LTP technique, after which it is transmitted. In the decoder the phases of the reconstructed signal at the spacing D in the past are determined. These phases are combined with the amplitudes already present in the frequency spectrum, after which transformation back to the time domain takes place. Inverse STP filtering is then carried out.